Related Experiment Videos

Evidence-based medication adherence in Hispanic patients with systolic heart failure in a disease management program

Kathy Hebert1, Julieta Beltran, Leonardo Tamariz

  • 1University of Miami Miller School of Medicine, FL 33136, USA. khebert1@gmail.com

Congestive Heart Failure (Greenwich, Conn.)
|July 29, 2010
PubMed

Insights

Hispanic patients show similar adherence to heart failure medications, including ACEIs/ARBs and BBs, compared to white and black patients in disease management programs.

Area of Science:

  • Cardiology
  • Health Disparities
  • Pharmacology

Background:

  • The Hispanic population is the fastest-growing minority in the U.S.
  • Limited data exist on heart failure disease management programs (HFDMPs) and medication adherence in Hispanic patients.
  • Understanding adherence is crucial for effective chronic disease management.

Purpose of the Study:

  • To measure evidence-based medication adherence (ACEIs/ARBs, BBs) in Hispanic patients within HFDMPs.
  • To compare medication adherence rates between Hispanic, white, and black populations.
  • To identify potential disparities in heart failure management.

Main Methods:

  • Cross-sectional study design.
  • Inclusion of 561 patients from a Heart Failure Disease Management Program (HFDMP) at Jackson Medical Hospital, Miami, Florida.
  • Data collection on the use of Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARBs) and Beta-Blockers (BBs).

Main Results:

  • At initial visit, 82% of Hispanic, 75% of white, and 79% of black patients were prescribed ACEIs/ARBs.
  • However, only 21% of Hispanic, 35% of white, and 32% of black patients were on target doses.
  • Hispanic patients demonstrated comparable compliance with ACEI/ARB and BB regimens to white and black patients.

Conclusions:

  • Hispanic patients exhibit similar adherence to ACEI/ARB and BB regimens as white and black patients in HFDMPs.
  • Socioeconomic factors may play a role in observed adherence patterns.
  • Findings suggest that HFDMPs can effectively manage heart failure in diverse populations.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...